(1S,3R)-N-{(3S,10S,12S,13R,17R)-12-Hydroxy-17- [(R)-5-hydroxypentan-2-yl]-10,13-dimethylhexa- decahydro-1H-cyclopenta[a]phenanthren-3-yl}- adamantane-1-carboxamide 0.25-hydrate

 

Kaydedildi:
Detaylı Bibliyografya
Yazarlar: Campos Fernández, Cristian Saúl, Procúpez Schtirbu, Rolando, Soto Tellini, Victor Hugo, Salazar Camacho, Juan Carlos, Jancik, Vojtech
Materyal Türü: artículo original
Yayın Tarihi:2022
Diğer Bilgiler:The title compound, C 35H 57 NO 3 0.25H 2O, was synthesized from deoxycholic acid followed by a protection, a Mitsonobu substitution, a Staudinger reduction, formation of an amide and final reduction in the lateral chain. The compound crystallizes in the P1 space group with four steroid molecules and one water molecule in the triclinic cell unit. The crystal structure features O—H O hydrogen bonding. The crystal studied was refined as a non-merohedral twin
Ülke:Kérwá
Kurum:Universidad de Costa Rica
Repositorio:Kérwá
Dil:Inglés
OAI Identifier:oai:kerwa.ucr.ac.cr:10669/87554
Online Erişim:https://iucrdata.iucr.org/x/issues/2022/10/00/bt4124/index.html
https://hdl.handle.net/10669/87554
Anahtar Kelime:Química Cristalografía
biological activity
crystal structure
bile salts